Xu F - Search Results

1

Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib.

Xu F, Wu J, Xue C, Zhao Y, Jiang W, Lin L, Wu X, Lu Y, Bai H, Xu J, Zhu G, Zhang L. Xu F, et al. Among authors: xu j. Onco Targets Ther. 2012;5:439-47. doi: 10.2147/OTT.S37289. Epub 2012 Dec 12. Onco Targets Ther. 2012. PMID: 23251095 Free PMC article.

2

[Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].

Zhang L, Zhang Y, Li N, Xu F, Pan ZK, Guan ZZ. Zhang L, et al. Among authors: xu f. Ai Zheng. 2004 Nov;23(11 Suppl):1455-8. Ai Zheng. 2004. PMID: 15566656 Clinical Trial. Chinese.

3

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].

Pan ZK, Zhang L, Zhang X, Wang X, Li N, Xu F, Chang JH, Guan ZZ. Pan ZK, et al. Among authors: xu f. Ai Zheng. 2005 Aug;24(8):919-23. Ai Zheng. 2005. PMID: 16086866 Chinese.

4

[High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].

Xu F, Zhang L, Xiang XJ, Wang ZQ, Zhou ZM, Wang SY. Xu F, et al. Ai Zheng. 2006 Sep;25(9):1120-2. Ai Zheng. 2006. PMID: 16965653 Chinese.

5

[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].

Zhang Y, Zhang L, Xu F, Wang ZQ, Zhao HY, Guan ZZ, Xu GC, Pan ZK. Zhang Y, et al. Among authors: xu f, xu gc. Ai Zheng. 2006 Dec;25(12):1561-4. Ai Zheng. 2006. PMID: 17166387 Chinese.

6

Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy.

Zhang L, Zhang Y, Huang PY, Xu F, Peng PJ, Guan ZZ. Zhang L, et al. Among authors: xu f. Cancer Chemother Pharmacol. 2008 Jan;61(1):33-8. doi: 10.1007/s00280-007-0441-8. Epub 2007 Mar 20. Cancer Chemother Pharmacol. 2008. PMID: 17909810 Clinical Trial.

7

[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].

Huang H, Zhang Y, Zhao HY, Wang ZQ, Xu F, Xu GC, Zhang L, Guan ZZ. Huang H, et al. Among authors: xu f, xu gc. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):148-51. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538895 Chinese.

8

[K-RAS gene mutations in patients with non-small cell lung cancer].

Zhang Y, Pan Z, Zhang X, Xu F, Zhang L. Zhang Y, et al. Among authors: xu f. Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):602-6. doi: 10.3779/j.issn.1009-3419.2010.06.007. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20681447 Free PMC article. Chinese.

9

[Tissue microarray analysis of HER2 protein expression in patients with non-small cell lung cancer].

Li N, Wang B, Zhang X, Pan Z, Xu F, Wang Z, Zhang Y, Zhang L. Li N, et al. Among authors: xu f. Zhongguo Fei Ai Za Zhi. 2006 Feb 20;9(1):50-4. doi: 10.3779/j.issn.1009-3419.2006.01.13. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21144282 Free article. Chinese.

10

[A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].

Zhang L, Li N, Xu F, Zhang Y. Zhang L, et al. Among authors: xu f. Zhongguo Fei Ai Za Zhi. 2005 Dec 20;8(6):530-4. doi: 10.3779/j.issn.1009-3419.2005.06.10. Zhongguo Fei Ai Za Zhi. 2005. PMID: 21208543 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,256 results

Search Page

Filters